PYXS
Income statement / Annual
Last year (2023), Pyxis Oncology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Pyxis Oncology, Inc.'s net income was -$73.79 M.
See Pyxis Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.00 M |
$1.84 M |
$1.25 M |
$444,000.00 |
$0.00 |
| Gross Profit |
-$2.00 M |
-$1.84 M |
-$1.25 M |
-$444,000.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$49.59 M
|
$86.13 M
|
$51.05 M
|
$9.05 M
|
$1.22 M
|
| General & Administrative
Expenses |
$32.61 M
|
$37.35 M
|
$18.66 M
|
$3.85 M
|
$1.66 M
|
| Selling & Marketing
Expenses |
-$1.78 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$30.83 M
|
$37.35 M
|
$18.66 M
|
$3.85 M
|
$1.66 M
|
| Other Expenses |
$0.00 |
$0.00 |
$181,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$82.20 M |
$123.48 M |
$69.72 M |
$12.89 M |
$2.88 M |
| Cost And Expenses |
$82.20 M |
$123.48 M |
$69.72 M |
$12.89 M |
$2.88 M |
| Interest Income |
$6.63 M |
$2.76 M |
$23,000.00 |
$66,000.00 |
$107,000.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2.00 M
|
$1.84 M
|
$1.25 M
|
$444,000.00
|
$2.88 M
|
| EBITDA |
-$78.49 M
|
-$122.77 M
|
-$69.07 M
|
-$12.43 M
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$8.41 M
|
$2.76 M
|
-$6.26 M
|
$66,000.00
|
$107,000.00
|
| Income Before Tax |
-$73.79 M |
-$120.72 M |
-$75.98 M |
-$12.83 M |
-$2.77 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$2.76 M |
$5.56 M |
-$66,000.00 |
-$107,000.00 |
| Net Income |
-$73.79 M |
-$117.95 M |
-$81.54 M |
-$12.76 M |
-$2.67 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.85 |
-3.57 |
-2.53 |
-0.37 |
-0.0777 |
| EPS Diluted |
-1.85 |
-3.57 |
-2.53 |
-0.37 |
-0.0777 |
| Weighted Average Shares
Out |
$39.90 M
|
$33.03 M
|
$32.22 M
|
$34.31 M
|
$34.31 M
|
| Weighted Average Shares
Out Diluted |
$39.90 M
|
$33.03 M
|
$32.22 M
|
$34.31 M
|
$34.31 M
|
| Link |
|
|
|
|
|
